Study reveal single-cell landscape of innate and acquired drug resistance in acute myeloid leukemia
Researchers from the Tumor Profiler consortium have combined single-cell multi-omics and functional profiling for 21 AML ...
Healthline10d
Overview of Secondary Acute Myeloid Leukemia
Secondary acute myeloid leukemia (AML) is a blood cancer that arises from other blood disorders or previous cancer treatment. Those with secondary AML tend to have a less favorable outlook than ...
The American Journal of Managed Care12d
After HMA Resistance in AML, a New Possible Therapy Option
When resistance to or failure of hypomethylating agents (HMAs) occurs in acute myeloid leukemia (AML), depleting a ligase ...
Aptose Biosciences Advances AML Triplet Therapy
Aptose Biosciences (TSE:APS) has released an update. Aptose Biosciences is advancing the development of its promising drug tuspetinib as part ...
Yahoo Finance7h
Moleculin Reports Third Quarter 2024 Financial Results and Provides Corporate Update
On track to start dosing in pivotal, adaptive Phase 3 clinical trial (the "MIRACLE" trial) designed for possible accelerated ...
kalkinemedia9h
Why Are Institutional Investors Eyeing Hemogenyx’s CAR-T Therapy...
Highlights,Hemogenyx Pharmaceuticals secures funding for phase I trials of its HEMO-CAR-T therapy.,The therapy focuses on ...
Targeted Oncology14d
FDA Fast Tracks HC-7366 in Relapsed/Refractory Acute Myeloid Leukemia
The FDA has granted fast track designation to HC-7366 for the treatment of adult patients with relapsed/refractory acute ...
Armed robbery in Revesby11d
Scientists Find Why Some Leukemia Cells Resist Treatment
Research from the Icahn School of Medicine at Mount Sinai provides new insights into acute myeloid leukemia (AML) and its ...
Helsinki Times13d
New test tailors leukemia treatment, boosts survival odds
A pioneering Finnish study has shown that drug sensitivity testing can help pinpoint which leukemia patients are likely to ...